# Prebys Ventures

> Prebys Ventures is a VC fund in San Diego backing Therapeutics, Finance and Medical. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: San Diego, United States
- Total investments: 4
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026

Prebys Ventures is a VC fund in San Diego focused on Therapeutics and Finance. Prebys Ventures is the venture capital arm of the Conrad Prebys Foundation.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 2 | 50% |
| Finance | 1 | 25% |
| Medical | 1 | 25% |
| Software | 1 | 25% |
| Biopharma | 1 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Series B | 1 | 25% |
| Series C | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Crystalys Therapeutics | Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout. | $130M | Series B | Jul 22, 2026 |  |
| Condor Software | Financial management software for biopharma | $24M | Series A | Mar 18, 2026 |  |
| Aspen Neuroscience | Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmetmedical needs, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs. | $115M | Series C | Nov 20, 2025 |  |
| Crystalys Therapeutics | Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout. | $205M | Series A | Sep 30, 2025 |  |

4 of 4 investments shown.

## Co-investors
- [Insight Partners](https://shizune.co/investors/profile/insight-partners) — VC Fund, 2 deals together
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 2 deals together
- [Perceptive Xontogeny Venture Fund](https://shizune.co/investors/profile/perceptive-xontogeny-venture-fund) — VC Fund, 2 deals together
- [Pontifax](https://shizune.co/investors/profile/pontifax) — VC Fund, 2 deals together
- [SR One](https://shizune.co/investors/profile/sr-one) — VC Fund, 2 deals together
- [Wedbush Healthcare Partners](https://shizune.co/investors/profile/wedbush-healthcare-partners) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Prebys Ventures invest in?

Prebys Ventures invests primarily in Therapeutics, Finance and Medical startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Prebys Ventures last invest?

The most recent investment recorded for Prebys Ventures closed in Jul 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co